Trials / Completed
CompletedNCT03104101
Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females
Evaluation of Transcutaneous Posterior Tibial Nerve Electro Stimulation With or Without Low Dose Trospium Chloride in the Management of Overactive Bladder in Females
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study was done to verify whether the combination of transcutaneous posterior tibial nerve stimulation (TPTNS) with low dose trospium chloride in the treatment of females with overactive bladder (OAB) would be more effective than TPTNS alone after failure of behavioral therapy.
Detailed description
The investigators randomized 30 women with OAB, in two groups: G I (15 patients) received 30 minutes TPTNS, three times a week; GII (15 patients) received TPTNS plus Low dose trospium chloride (20 mg once daily); all for 8 weeks. Patients were evaluated using Overactive Bladder Symptom Score questionnaire (OABSS), Incontinence Impact Questionnaire-short form 7 (IIQ-7), 3 day voiding diary and urodynamics at weeks 0 and 8.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | TPTNS+Drug | one tablet Trospium Chloride 20 mg once daily Plus TPTNS |
| DEVICE | TPTNS | Surface adhesive electrodes placed on the skin above medial malleolus |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-11-30
- Completion
- 2016-03-05
- First posted
- 2017-04-07
- Last updated
- 2017-04-07
Source: ClinicalTrials.gov record NCT03104101. Inclusion in this directory is not an endorsement.